ArticleMolecular therapy oncolytics2022

Development of STEAP1 targeting chimeric antigen receptor for adoptive cell therapy against cancer.

Yixin Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.